HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CF PHARMTECH

20.380

0.000

Volume:- -

Turnover:- -

Market Cap:8.38B

PE:2.66K

High:20.380

Open:20.380

Low:20.380

Close:20.380

52wk High:48.800

52wk Low:18.100

Shares:411.00M

HK Float Shares:302.00M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.008

ROE:0.21%

ROA:-0.83%

PB:4.92

PE(LYR):2,664.75

PS:16.71

Loading ...

Overview Company News Filings

CF Pharmtech files HKEX next-day disclosure, repurchases shares at HKD 21.71 each

CF PharmTech Discloses April 2026 Share Capital Update; 0.16 Million H-Shares Added to Treasury

Bulletin Express

CF PHARMTECH (02652) Allocates HK$144,400 for Share Buyback on May 5

CF Pharmtech files HKEX disclosure return, repurchases shares at HKD 22.22 each

CF PharmTech repurchases 5,500 H shares; treasury holdings climb to 0.22% of issued shares

Bulletin Express

CF PHARMTECH (02652) Repurchases 5,500 Shares for HK$123,000 on May 4

CF Pharmtech files HKEX next-day return disclosing share repurchase at HKD 22.45

14 Innovative Class 1 Drugs Receive Clinical Trial Approval in China from CF Pharmtech, Hengrui Pharma, and Others

CF PHARMTECH 2025年营收同比下降、利润下滑逾八成，净资产同比大幅提升

Bulletin Express

CF PharmTech Releases 2025 ESG Report: Revenue at RMB 432.52 Million, Net Profit Turns Positive, R&D Spend Hits RMB 124.55 Million

Bulletin Express

CF PharmTech publishes 2025 annual report

CF PHARMTECH (02652) Allocates HK$529,700 for Share Buyback on April 30

CF PharmTech repurchases 24,000 H shares, spending HKD 0.53 million

Bulletin Express

CF Pharmtech files HKEX next-day return disclosing buyback at HKD 22.07/share

CF PHARMTECH (02652) Spends HK$83,000 on Share Buyback on April 28

CF PharmTech repurchases 4,000 H-shares at HK$20.82 apiece, lifting treasury stock to 641,000 shares

Bulletin Express

CF PharmTech files HKEX next-day return, discloses buyback at HKD 20.82/share

CF PHARMTECH Shares Climb Over 5% on Key Clinical Milestone for In-House EBV Device

CF PharmTech executes HK$0.11 million share buy-back; treasury stock rises to 637,000 shares

Bulletin Express

CF PHARMTECH (02652) Repurchases 5,500 Shares for HK$114,000 on April 27

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02652/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"CF PHARMTECH","latestPrice":20.38,"timestamp":1780448400671,"preClose":20.38,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":302000000,"shares":411000000,"eps":0.007647738102702363,"marketStatus":"Pre-opening","change":0,"latestTime":"06-03 09:05:32","open":20.38,"high":20.38,"low":20.38,"amount":0,"amplitude":0,"askPrice":22.24,"askSize":500,"bidPrice":19.7,"bidSize":500,"shortable":3,"etf":0,"ttmEps":0.007647738102702363,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1780450200000},"marketStatusCode":1,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":20.38,"openAndCloseTimeList":[[1780450200000,1780459200000],[1780462800000,1780473600000]],"volumeRatio":0,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":302000000,"roa":"-0.83%","roe":"0.21%","lyrEps":0.007648,"shares":411000000,"dividePrice":0,"high":20.38,"amplitude":0,"preClose":20.38,"low":20.38,"week52Low":18.1,"pbRate":"4.92","psRate":"16.71","week52High":48.8,"institutionHeld":0,"latestPrice":20.38,"eps":0.007647738102702363,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.007647738102702363,"open":20.38,"prevYearClose":35,"fiveDayClose":19.66,"twentyDayClose":22.02,"sixtyDayClose":37.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[{"date":"2026-03-30","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2026-06-01","current":2665.19987,"percent":0.839744,"low":-293.764894,"twenty":400.575047,"median":467.575731,"eighty":2963.886694,"high":3595.964728,"avg":1098.551773,"sd":1175.771413,"marketCap":8746652155},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106},{"date":"2025-10-31","current":411.638127,"twenty":385.87135,"median":395.798507,"eighty":410.009732,"marketCap":12482945126},{"date":"2025-11-07","current":380.629431,"twenty":385.87135,"median":397.412529,"eighty":410.009732,"marketCap":11535394836},{"date":"2025-11-14","current":413.442652,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"marketCap":12565340803},{"date":"2025-11-21","current":474.663516,"twenty":387.596392,"median":401.654037,"eighty":419.1227,"marketCap":14419243545},{"date":"2025-11-28","current":513.213561,"twenty":390.697015,"median":408.734506,"eighty":451.19497,"marketCap":15646939138},{"date":"2025-12-05","current":509.365027,"twenty":391.797785,"median":411.605323,"eighty":487.699676,"marketCap":15556303893},{"date":"2025-12-12","current":478.26383,"twenty":394.588712,"median":413.442652,"eighty":485.541496,"marketCap":14633472306},{"date":"2025-12-19","current":468.273561,"twenty":396.041553,"median":429.606948,"eighty":482.974301,"marketCap":14361566570},{"date":"2025-12-24","current":469.497744,"twenty":396.770692,"median":439.211078,"eighty":482.563912,"marketCap":14443962248},{"date":"2026-01-02","current":452.984556,"twenty":397.492287,"median":451.385447,"eighty":481.570975,"marketCap":13990786022},{"date":"2026-01-09","current":417.797013,"twenty":398.674444,"median":438.955991,"eighty":480.057858,"marketCap":12936121351},{"date":"2026-01-16","current":442.060347,"twenty":399.985866,"median":432.778937,"eighty":478.730146,"marketCap":13731858722},{"date":"2026-01-23","current":466.639698,"twenty":400.772068,"median":439.902936,"eighty":477.371374,"marketCap":14481468286},{"date":"2026-01-30","current":480.840623,"twenty":401.791027,"median":446.916666,"eighty":477.757159,"marketCap":14990389486},{"date":"2026-02-06","current":464.022312,"twenty":403.190746,"median":452.185001,"eighty":477.033593,"marketCap":14502764350},{"date":"2026-02-13","current":452.173894,"twenty":406.744138,"median":454.320794,"eighty":475.6532,"marketCap":14213623359},{"date":"2026-02-20","current":472.094804,"twenty":408.734506,"median":454.916554,"eighty":476.776403,"marketCap":14818441932},{"date":"2026-02-27","current":505.751529,"twenty":411.273773,"median":459.838493,"eighty":479.42962,"marketCap":16048983093},{"date":"2026-03-06","current":445.246344,"twenty":411.572519,"median":460.887466,"eighty":481.94993,"marketCap":14015073071},{"date":"2026-03-13","current":299.287031,"twenty":402.338985,"median":457.528006,"eighty":481.000215,"marketCap":9464083401},{"date":"2026-03-20","current":315.053976,"twenty":397.81132,"median":454.320794,"eighty":480.840623,"marketCap":9924943114},{"date":"2026-03-27","current":299.095644,"twenty":391.175665,"median":451.779671,"eighty":479.42962,"marketCap":9398246299},{"date":"2026-04-02","current":3318.248683,"twenty":389.832113,"median":451.779671,"eighty":480.872541,"marketCap":9381570423},{"date":"2026-04-10","current":3321.445916,"twenty":390.816678,"median":452.984556,"eighty":482.236241,"marketCap":9463036901},{"date":"2026-04-17","current":3317.060015,"twenty":392.419904,"median":455.282385,"eighty":483.410603,"marketCap":9454509433},{"date":"2026-04-24","current":2996.4431,"twenty":394.891161,"median":460.26919,"eighty":490.336167,"marketCap":8541149514},{"date":"2026-04-30","current":3202.871531,"twenty":396.041553,"median":462.144769,"eighty":499.979081,"marketCap":9131900891},{"date":"2026-05-08","current":3148.404437,"twenty":397.173254,"median":463.774025,"eighty":508.169798,"marketCap":9007763175},{"date":"2026-05-15","current":2973.181714,"twenty":398.099028,"median":464.50673,"eighty":512.854422,"marketCap":8528814526},{"date":"2026-05-22","current":2811.882705,"twenty":399.495195,"median":466.720409,"eighty":2921.871357,"marketCap":8047680823},{"date":"2026-05-29","current":3180.044455,"twenty":400.476536,"median":467.247998,"eighty":2926.706614,"marketCap":9133017429},{"date":"2026-06-01","current":3038.815931,"twenty":400.575047,"median":467.575731,"eighty":2963.886694,"marketCap":8746652155}],"updateTime":1780422376486},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633149941","title":"CF Pharmtech files HKEX next-day disclosure, repurchases shares at HKD 21.71 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149941","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633149941?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:34","pubTimestamp":1778153683,"startTime":"0","endTime":"0","summary":"CF Pharmtech repurchased 10,500 H shares on May 7 at HKD 21.6 to HKD 21.86 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLbb9c6C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164128856","title":"CF PharmTech Discloses April 2026 Share Capital Update; 0.16 Million H-Shares Added to Treasury","url":"https://stock-news.laohu8.com/highlight/detail?id=1164128856","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164128856?lang=en_us&edition=fundamental","pubTime":"2026-05-07 17:04","pubTimestamp":1778144677,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (H-share: 02652) filed its Monthly Return for Equity Issuer for the period ended 30 April 2026, confirming minor movements in issued share capital and continued compliance with...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167775740","title":"CF PHARMTECH (02652) Allocates HK$144,400 for Share Buyback on May 5","url":"https://stock-news.laohu8.com/highlight/detail?id=1167775740","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167775740?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:20","pubTimestamp":1777983615,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on May 5, 2026, the company repurchased 6,500 of its shares at a total cost of HK$144,400.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633910771","title":"CF Pharmtech files HKEX disclosure return, repurchases shares at HKD 22.22 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2633910771","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633910771?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:15","pubTimestamp":1777983304,"startTime":"0","endTime":"0","summary":"CF Pharmtech repurchased 6,500 H shares on May 5 at HKD 21.96 to HKD 22.66 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL6dwqy8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143544591","title":"CF PharmTech repurchases 5,500 H shares; treasury holdings climb to 0.22% of issued shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1143544591","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143544591?lang=en_us&edition=fundamental","pubTime":"2026-05-04 18:44","pubTimestamp":1777891450,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (H-share) disclosed a share buyback executed on 04 May 2026. Key details are as follows: • Transaction size and price: 5,500 H shares were repurchased on the Hong Kong Stock...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121916350","title":"CF PHARMTECH (02652) Repurchases 5,500 Shares for HK$123,000 on May 4","url":"https://stock-news.laohu8.com/highlight/detail?id=1121916350","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121916350?lang=en_us&edition=fundamental","pubTime":"2026-05-04 18:42","pubTimestamp":1777891345,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on May 4, 2026, the company repurchased 5,500 of its shares at a total cost of HK$123,000.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632932136","title":"CF Pharmtech files HKEX next-day return disclosing share repurchase at HKD 22.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2632932136","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632932136?lang=en_us&edition=fundamental","pubTime":"2026-05-04 18:37","pubTimestamp":1777891055,"startTime":"0","endTime":"0","summary":"CF Pharmtech repurchased 5,500 H shares on May 4 at HKD 22.45 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL25QQDc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104229028","title":"14 Innovative Class 1 Drugs Receive Clinical Trial Approval in China from CF Pharmtech, Hengrui Pharma, and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=1104229028","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104229028?lang=en_us&edition=fundamental","pubTime":"2026-05-03 16:51","pubTimestamp":1777798286,"startTime":"0","endTime":"0","summary":"According to information compiled from the official website of China's Center for Drug Evaluation (CDE) and public sources, 14 Class 1 innovative drugs received their first clinical trial approval in...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1781817850.SGD","LU1255011170.USD","LU1997245177.USD","BK0183","LU2097828805.USD","LU1580142542.USD","LU0359201885.HKD","BK0060","LU1820825898.SGD","LU2148510915.USD","BK0012","BK0028","BK0196","LU1997244956.HKD","LU1023057109.AUD","LU0359202008.SGD","LU0405327148.USD","600276","LU1146622755.USD","BK0188","BK1191","LU2097828631.EUR","LU2097828714.EUR","BK0239","LU2580892862.HKD","LU0359201612.USD","LU2328871848.SGD","LU2097828557.USD","LU0405327494.USD","LU1969619763.USD","01276","LU2488822045.USD","LU1328615791.USD","LU2543165471.USD","LU2580892789.USD","02652","LU1997245094.SGD","LU2097828474.EUR","LU2289578879.USD","LU1064130708.USD","LU1655091616.SGD","LU1064131003.USD","LU2495084118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173816529","title":"CF PHARMTECH 2025年营收同比下降、利润下滑逾八成，净资产同比大幅提升","url":"https://stock-news.laohu8.com/highlight/detail?id=1173816529","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173816529?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:46","pubTimestamp":1777553206,"startTime":"0","endTime":"0","summary":"CF PHARMTECH于2025年度在经营与财务方面经历多重变化，全年营收和盈利能力承压，但资产规模与股本结构实现显著提升，显示出公司在研发、产品结构及国际化布局等领域的持续投入与调整。 一、业务表现与经营情况...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CF PHARMTECH 2025年营收同比下降、利润下滑逾八成，净资产同比大幅提升","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184143505","title":"CF PharmTech Releases 2025 ESG Report: Revenue at RMB 432.52 Million, Net Profit Turns Positive, R&D Spend Hits RMB 124.55 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1184143505","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184143505?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:45","pubTimestamp":1777553105,"startTime":"0","endTime":"0","summary":"CF PharmTech published its first standalone Environmental, Social and Governance (ESG) report, covering the financial year ended 31 December 2025. The document combines operating data with detailed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631632291","title":"CF PharmTech publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631632291","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631632291?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:31","pubTimestamp":1777552286,"startTime":"0","endTime":"0","summary":"CF PharmTech annual report for year ended Dec. 31, 2025 flagged transition from China-focused inhaled formulations business toward global inhalation delivery platform strategy.Performance weakened as CF017 faced price pressure under VBP renewal, slower procurement execution, softer respiratory infection demand, and disruption from sales network restructuring.Product mix shifted as CF018 scaled up following reimbursement inclusion, supporting effort to reduce reliance on CF017.Overseas business moved into initial delivery stage, generating overseas revenue above RMB 10 million in 2025; cumulative overseas orders surpassed 16 million units.Pipeline advanced with IND acceptance for ICF001 in March 2026 and ICF004 in February 2026, supporting push into innovative inhaled therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informatio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL31yJkg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198849632","title":"CF PHARMTECH (02652) Allocates HK$529,700 for Share Buyback on April 30","url":"https://stock-news.laohu8.com/highlight/detail?id=1198849632","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198849632?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:10","pubTimestamp":1777543842,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 30, the company repurchased 24,000 of its shares at a cost of HK$529,700. The price per share ranged from HK$21.86 to HK$22.26.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199879514","title":"CF PharmTech repurchases 24,000 H shares, spending HKD 0.53 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1199879514","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199879514?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:04","pubTimestamp":1777543476,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (02652.HK) bought back 24,000 H-shares on the Hong Kong Stock Exchange on 30 April 2026. The repurchase was executed at prices ranging from HKD 21.86 to HKD 22.26 per share,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631824826","title":"CF Pharmtech files HKEX next-day return disclosing buyback at HKD 22.07/share","url":"https://stock-news.laohu8.com/highlight/detail?id=2631824826","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631824826?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:00","pubTimestamp":1777543202,"startTime":"0","endTime":"0","summary":"CF PharmTech reported repurchase of 24,000 H shares on Exchange on April 30, 2026.Buyback price range HKD 21.86 to HKD 22.26 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL54r2lt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192575019","title":"CF PHARMTECH (02652) Spends HK$83,000 on Share Buyback on April 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1192575019","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192575019?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:27","pubTimestamp":1777379261,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that it repurchased 4,000 of its shares on April 28, 2026, at a total cost of HK$83,000.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106138707","title":"CF PharmTech repurchases 4,000 H-shares at HK$20.82 apiece, lifting treasury stock to 641,000 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1106138707","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106138707?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:23","pubTimestamp":1777379032,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. filed a Next Day Disclosure Return on 28 April 2026, confirming a minor share buyback executed the same day on the Hong Kong Stock Exchange. • Transaction details: 4,000 ordinary...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630304357","title":"CF PharmTech files HKEX next-day return, discloses buyback at HKD 20.82/share","url":"https://stock-news.laohu8.com/highlight/detail?id=2630304357","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630304357?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:21","pubTimestamp":1777378882,"startTime":"0","endTime":"0","summary":"CF PharmTech repurchased 4,000 H shares on April 28.Buyback price range was HKD 20.7 to HKD 21.04 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 28, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDLGQZvc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129431759","title":"CF PHARMTECH Shares Climb Over 5% on Key Clinical Milestone for In-House EBV Device","url":"https://stock-news.laohu8.com/highlight/detail?id=1129431759","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129431759?lang=en_us&edition=fundamental","pubTime":"2026-04-28 15:40","pubTimestamp":1777362039,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) rose more than 5%. At the time of writing, the stock was up 3.34%, trading at HK$21.64 with a turnover of HK$10.7456 million. On the news front, on April 27, CF PHARMTECH...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK4585","02652","VXUS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113173013","title":"CF PharmTech executes HK$0.11 million share buy-back; treasury stock rises to 637,000 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1113173013","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113173013?lang=en_us&edition=fundamental","pubTime":"2026-04-27 18:23","pubTimestamp":1777285432,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. disclosed a repurchase of 5,500 H-shares on 27 April 2026, according to its Next Day Disclosure Return filed with the Hong Kong Stock Exchange on the same date. The shares were...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151288999","title":"CF PHARMTECH (02652) Repurchases 5,500 Shares for HK$114,000 on April 27","url":"https://stock-news.laohu8.com/highlight/detail?id=1151288999","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151288999?lang=en_us&edition=fundamental","pubTime":"2026-04-27 18:18","pubTimestamp":1777285136,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 27, 2026, the company repurchased 5,500 of its own shares at a total cost of HK$114,000.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":185,"code":"91000000","status":"200"}]}}